Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Massimo C Fantini
Phase I Clinical Trial of Smad7 Knockdown Using Antisense Oligonucleotide in Patients With Active Crohn's Disease
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Related publications
Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn's Disease
New England Journal of Medicine
Medicine
Clinical Benefit of Antisense Therapy in a Phase III Trial in Patients With CLL
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Antisense Oligonucleotide Therapy for Neurodegenerative Disease
Journal of Clinical Investigation
Medicine
Phase I/Ii Study of G3139 (Bcl-2 Antisense Oligonucleotide) in Combination With Doxorubicin and Docetaxel in Breast Cancer
Clinical Cancer Research
Cancer Research
Oncology
A Phase 3 Clinical Trial With ISIS-TTRRx, a 2nd-Generation Antisense Oligonucleotide Targeting Transthyretin (TTR), for the Treatment of TTR Amyloid Cardiomyopathy
Orphanet Journal of Rare Diseases
Medicine
Genetics
Pharmacology
GLI2 Knockdown Using an Antisense Oligonucleotide Induces Apoptosis and Chemosensitizes Cells to Paclitaxel in Androgen-Independent Prostate Cancer
Clinical Cancer Research
Cancer Research
Oncology
Effect of Sulphasalazine in Patients With Active Crohn's Disease: A Controlled Double-Blind Study.
Gut
Gastroenterology
Platelet Count in Patients With Crohn's Disease
BMJ
Phase I Clinical Trial of Multiple-Peptide Vaccination for Patients With Advanced Biliary Tract Cancer
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
